Scleroderma Foundation eLetter

Archive

Renal Scleroderma

By the late Joseph Korn, M.D., Alan S. Cohen Professor of Medicine in Rheumatology, and Director, Section of Rheumatology and Arthritis Center, Boston University School of Medicine (originally published in "Scleroderma Voice," 2003 #1)


Friday, December 1, 2006– Issue #170	eLetter Archive

"Evolving Complexities and Therapeutic Strategies in PAH"

What are the differences between selective and dual endothelin receptor antagonists? This review looks at the evolving complexities in selecting a treatment for PAH. (May require free registration to Medscape.com.)

The End of the Year Is Gift Giving Time—an Ideal Time to Give the Gift of a Scleroderma Foundation Membership

It’s a common dilemma at this time of the year—you have gifts to buy. You have also been scratching your head, wondering what to get them.

Pulmonary Hypertension Patients Improve from Combination Therapy

For patients with pulmonary arterial hypertension (PAH), adding inhaled iloprost to treatment with bosentan—two different classes of drugs often used individually to treat PAH—increases exercise capability, reduces clinical deterioration and, in some cases, improves diagnostic functional class by one stage.

Upcoming Events

	November 29–December 3 (Wed.–Sun.): 5th International Congress on Autoimmunity (Sorento, Italy)
	December 2 (Sat.): Greater Chicago Chapter's Fall-Winter Seminar (Chicago, Ill.)
	December 4 (Mon.): Southeast Florida Chapter's Holiday Party/General Meeting (Pompano Beach, Fla.)
SF Calendar

Scleroderma Foundation, 300 Rosewood Drive, Suite 105, Danvers, MA 01923
Phone 978-463-5843 · 800-722-HOPE (4673)

If you cannot view the eLetter, or the links do not work, you can read it on the Web at www.scleroderma.org/e-letters/eLetter_170.htm. If someone has forwarded this eLetter to you, and you wish to subscribe to this FREE weekly publication, go to www.scleroderma.org/e_letter_signup.shtm.